Plasma HER2 (ERBB2) copy number to predict response to HER2-targeted therapy in metastatic colorectal cancer.

被引：4

作者：

Bardelli, Alberto

Siravegna, Giulia

Sartore-Bianchi, Andrea

Nagy, Rebecca J.

Mussolin, Benedetta

Cassingena, Andrea

Martino, Cosimo

Lonardi, Sara

Zagonel, Vittorina

Leone, Francesco

Amatu, Alessio

Trusolino, Livio

Odegaard, Justin

Lanman, Richard B.

Marsoni, Silvia

Siena, Salvatore

机构：

[1] IRCCS, Fdn Piemonte Oncol, Ist Candiolo, Candiolo, Italy

[2] Grande Osped Metropolitano Niguarda, Milan, Italy

[3] Guardant Hlth Inc, Redwood City, CA USA

[4] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy

[5] Ist Oncol Veneto IRCCS, Padua, Italy

[6] IOV IRCCS, Veneto Inst Oncol, Dept Clin & Expt Oncol, Med Oncol 1, Padua, Italy

[7] Univ Turin, FPO, IRCCS, Div Med Oncol,Candiolo Canc Inst, Candiolo, Italy

[8] Guardant Hlth, Redwood City, CA USA

[9] Grande Osped Metropolitano Niguarda, Dept Hematol & Oncol, Niguarda Canc Ctr, Milan, Italy

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.3506

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3506

引用

页数：1